Phase 1 · Clozapine

Clozapine monitoring, without the clinic visit.

The most effective treatment for treatment-resistant schizophrenia, made accessible by moving haematological monitoring into the home.

Hands at a kitchen table preparing an at-home finger-prick blood test

At a glance

Weekly → Home
Testing moves from clinic to home
~ 15 min
Per test
Audit-ready
Full audit trail for every result

The problem

When the clinic visit is the barrier to treatment.

01

Weekly venous bloods at a clinic are a significant access barrier for patients with severe mental illness.

02

Missed appointments lead to dispensing being withheld, destabilising patients who finally had an effective treatment.

03

Trusts carry the full cost of phlebotomy capacity dedicated to clozapine surveillance.

For patients

Test at home, keep your medication.

A finger-prick neutrophil reading takes minutes at home and is reviewed remotely, with no clinic and no waiting room.

For trusts

An audit trail your service can rely on.

Results flow into a clinician dashboard with a full audit trail, reviewed by the responsible clinician, supporting existing monitoring and service governance.

See the platform

How it works

At home, every week.

Proxima ships to the patient with a clozapine-specific protocol. Results arrive in the Health Hub in minutes, with neutropenia alerts escalating directly to the responsible clinician.

Meet Proxima

A weekly check, redefined.

01

Test from home

Single cartridge, finger prick or shoulder patch, about 15 minutes.

02

Audit-ready result

Neutrophil count returned with full audit trail.

03

Clinician review

The responsible clinician reviews the result.

04

Continuity of care

No missed dose, no relapse, no clinic burden.

Solutions

Bring regular immune monitoring to your patients.

Book a 20-minute briefing with our clinical team to see Algocyte in action.